 hiv antigen variabl arc/aid natur variabl human immunodefici viru antigen hiv Ag time untreat hiv-infect patient percentag chang serum hiv Ag antigenem arc/aid subject placebo week clinic trial month observ differ hiv Ag chang month observ period monthli chang median subject mean monthli hiv Ag chang chang standard deviat increas decreas hiv Ag chang length observ month possibl pairwis combin hiv Ag level t-cell chang whole studi hiv Ag chang period knowledg broad hiv Ag variabl use sampl size categor respons unlik clinic trial antivir agent hiv Ag chang surrog marker efficaci